GENERIC NAME: RINGERS/LACTATED RINGERS SOLUTION - INTRAVENOUS (RING-ers; LACK-tay-ted RING-ers)
Medication Uses | How To Use | Side Effects | Precautions | Drug Interactions | Overdose | Notes | Missed Dose | Storage
USES: This medication is an intravenous (IV) solution used to supply water and electrolytes (e.g., calcium, potassium, sodium, chloride), either with or without calories (dextrose), to the body. It is also used as a mixing solution (diluent) for other IV medications.
HOW TO USE: Give this medication by vein (IV), as directed by you doctor. The dosage is based on your medical condition and response to therapy. Follow all instructions for proper mixing with other IV medications. Ask your pharmacist if you have any questions regarding the use of this medication. This medication should be checked visually for particles or discoloration before use. If either is present, do not use the liquid. Learn how to store and discard needles and medical supplies safely. Consult your pharmacist.
SIDE EFFECTS: Redness or pain at the injection site may occur. If any of these effects persist or worsen, contact your doctor or pharmacist promptly. Tell your doctor immediately if any of these unlikely but serious side effects occur: fever, trouble breathing, swelling. If you notice other effects not listed above, contact your doctor or pharmacist.
PRECAUTIONS: Tell your doctor your medical history, especially of: diabetes, heart problems, kidney problems, liver problems, high levels of potassium (hyperkalemia), high levels of sodium (hypernatremia), acid/base problems (e.g., acidosis, alkalosis), swelling (edema), allergies (especially drug allergies). Caution is advised when using this drug in infants since they may be more sensitive to the effects of the drug. Tell your doctor if you are pregnant before using this medication. It is unknown if this medication passes into breast milk. Consult your doctor before breast-feeding.
 |
 |
From the Doctors at MedicineNet.com  |
 |
Back to Medications IndexLast Editorial Review: 3/2/2005